Blood leukocytes from benznidazole-treated indeterminate chagas disease patients display an overall type-1-modulated cytokine profile upon short-term in vitro stimulation with trypanosoma cruzi antigens
BMC Infectious Diseases, 05/25/2012SathlerAvelar R et al. –
Together, the findings showed that the Bz treatment of Indeterminate Chagas' disease patients shifts the cytokine patterns of peripheral blood monocytes, NK–cells and CD8+ Tcells towards a long–lasting Type–1–modulated profile that could be important to the maintenance of a non–deleterious immunological microenvironment.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.